Copyright
©The Author(s) 2025.
World J Hepatol. Jan 27, 2025; 17(1): 101704
Published online Jan 27, 2025. doi: 10.4254/wjh.v17.i1.101704
Published online Jan 27, 2025. doi: 10.4254/wjh.v17.i1.101704
Biochemical parameters | Baseline | 12 weeks | 24 weeks | P value |
Leukocytes in thousands/μL1 | 6.6 (4.1-9.5) | 6.3 (4-9.6) | 7.7 (4.2-9.9) | 0.050 |
Hb in g/dL2 | 13.1 + 1.4 | 13.0 + 1.3 | 12.9 + 2.3 | 0.071 |
Platelets in miles/μL2 | 278 + 73 | 254 + 59 | 251 + 50 | 0.107 |
TB in mg/dL2 | 0.52 + 0.32 | 0.65 + 0.40 | 0.72 + 0.33 | 0.001 |
AST in U/L1 | 24 (12-148) | 29 (18-110) | 25 (17-75) | 0.185 |
ALT in U/L1 | 30 (10-137) | 30 (15-97) | 28 (18-86) | 0.644 |
ALP in IU/L2 | 101 + 41 | 86 + 30 | 38 + 18 | 0.011 |
GGT in U/L1 | 36 (19-198) | 26 (11-152) | 72 (28-98) | 0.160 |
TP in g/dL1 | 7.3 (6.3-8.8) | 7.4 (6.6-8.8) | 7.7 (6.7-8.9) | 0.661 |
Albumin in g/dL2 | 4.00 + 0.57 | 4.20 + 0.59 | 7.50 + 0.52 | 0.056 |
Cholesterol in mg/dL2 | 195 + 51 | 203 + 39 | 185 + 39 | 0.457 |
HDL in mg/dL1 | 44 (23-66) | 44 (32-70) | 48 (27-95) | 0.213 |
LDL in mg/dL2 | 125 + 53 | 128 + 37 | 110 + 35 | 0.425 |
VLDL in mg/dL2 | 31.0 + 14.0 | 29.0 + 10.0 | 27.0 + 9.6 | 0.041 |
Triglycerides in mg/dL2 | 151 + 67 | 145 + 51 | 138 + 48 | 0.116 |
Glucose in mg/dL1 | 104 (71-175) | 91 (81-148) | 108 (90-177) | 0.332 |
Creatinine in mg/dL2 | 0.76 + 0.21 | 0.66 + 0.13 | 0.69 + 0.20 | 0.233 |
CRP in mg/L1 | 2.70 (0.40-1.45) | 0.80 (0.70-0.90) | 0.27 (0.03-3.10) | 0.018 |
Insulin in mg/L2 | 8.8 + 6.7 | 20.0 + 10.0 | 15.9 + 6.2 | 0.015 |
HOMA2 | 5.6 + 4.6 | 5.1 + 3.0 | 4.1 + 1.9 | 0.497 |
- Citation: Cano Contreras AD, Del Rocío Francisco M, Vargas Basurto JL, Gonzalez-Gomez KD, Amieva-Balmori M, Roesch Dietlen F, Remes-Troche JM. Effect of alpha-lipoic acid and Silybum marianum supplementation with a Mediterranean diet on metabolic dysfunction-associated steatosis. World J Hepatol 2025; 17(1): 101704
- URL: https://www.wjgnet.com/1948-5182/full/v17/i1/101704.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i1.101704